Pesquisar
Apimeds Pharmaceuticals US Inc
APUSAdicionar à lista de desejos
5.150USD
+0.230+4.67%
Fechamento 07-31 16:00（ET）Cotações atrasadas em 15 min
64.77MValor de mercado
PerdaP/L TTM
Mais detalhes de Apimeds Pharmaceuticals US Inc Empresa
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox as a potential osteoarthritis (OA) treatment for patients with knee pain who failed to respond adequately to conservative non- pharmacologic therapy and simple analgesics.
Informações de Apimeds Pharmaceuticals US Inc
Código da empresaAPUS
Nome da EmpresaApimeds Pharmaceuticals US Inc
Data de listagemMay 09, 2025
CEOMenon (Vin)
Número de funcionários2
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 09
Endereço100 Matawan Road
CidadeMATAWAN
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísUnited States of America
Código postal07747
Telefone18482015010
Sitehttps://www.apimedsus.com/
Código da empresaAPUS
Data de listagemMay 09, 2025
CEOMenon (Vin)
Executivos da empresa Apimeds Pharmaceuticals US Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Erik C. Emerson
Mr. Erik C. Emerson
President, Director
President, Director
750.00K
--
Mr. Jakap Koo
Mr. Jakap Koo
Director
Director
615.38K
-4.63%
Dr. Bennett Weintraub, Ph.D.
Dr. Bennett Weintraub, Ph.D.
Independent Director
Independent Director
--
--
Ms. Carol O'Donnell
Ms. Carol O'Donnell
Independent Director
Independent Director
--
--
Ms. Elona Kogan, Esq.
Ms. Elona Kogan, Esq.
Independent Director
Independent Director
--
--
Mr. Erick Frim
Mr. Erick Frim
Chief Financial Officer
Chief Financial Officer
--
--
Vin Menon
Vin Menon
Chief Executive Officer, Director - Designee
Chief Executive Officer, Director - Designee
--
--
Mr. Amir Dossal
Mr. Amir Dossal
Director - Designee
Director - Designee
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Erik C. Emerson
Mr. Erik C. Emerson
President, Director
President, Director
750.00K
--
Mr. Jakap Koo
Mr. Jakap Koo
Director
Director
615.38K
-4.63%
Dr. Bennett Weintraub, Ph.D.
Dr. Bennett Weintraub, Ph.D.
Independent Director
Independent Director
--
--
Ms. Carol O'Donnell
Ms. Carol O'Donnell
Independent Director
Independent Director
--
--
Ms. Elona Kogan, Esq.
Ms. Elona Kogan, Esq.
Independent Director
Independent Director
--
--
Mr. Erick Frim
Mr. Erick Frim
Chief Financial Officer
Chief Financial Officer
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Apimeds Pharmaceuticals US Inc?
Os cinco principais acionistas de Apimeds Pharmaceuticals US Inc são: Mr. Erik C. Emerson